Back to top

Underwriting Agreement

Underwriting Agreement

Underwriting Agreement You are currently viewing:
This Underwriting Agreement involves

DUKE REALTY CORP

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Underwriting Agreement
Governing Law: New York     Date: 2/21/2008
Industry: REOPER     Law Firm: Alston Bird     Sector: SERVIC

Search Underwriting Agreement by:

Document Title:

Entire Document: (optional)

50 of the Top 250 law firms use our Products every day

Exhibit 1.1

 

EXECUTION COPY

 

DUKE REALTY CORPORATION

(an Indiana Corporation)

 

11,000,000 Depositary Shares

 

Each Representing 1/10 of a 8.375% Series O Cumulative Redeemable

Preferred Share (Par Value $0.01 Per Share)

(Liquidation Preference Equivalent to $25.00 Per Depositary Share)

 

TERMS AGREEMENT

 

Dated: As of February 14, 2008

 

To:

Duke Realty Corporation

 

Duke Realty Limited Partnership

 

600 East 96 th Street, Suite 100

 

Indianapolis, IN  46240

 

Attention:  Chairman of the Board of Directors

 

Ladies and Gentlemen:

 

We understand that Duke Realty Corporation, an Indiana corporation (the “ Company ”), proposes to issue and sell 11,000,000 depositary shares (the “ Depositary Shares ”) each representing 1/10th of a 8.375% Series O Cumulative Redeemable Preferred Share, par value $0.01 (collectively, the “ Series O Preferred Shares ”), of the Company (such Depositary Shares being collectively hereinafter referred to as the “ Underwritten Securities ”).  Subject to the terms and conditions set forth or incorporated by reference herein, the underwriters named below (the “ Underwriters ”) offer to purchase the Initial Securities (as defined in the Underwriting Agreement referred to below) set forth below opposite their respective names, and a proportionate share of Option Securities (as defined in the Underwriting Agreement referred to below) at the purchase price set forth below.  For purposes of this offering, the term “ Registration Statement ” (as defined in the Underwriting Agreement referred to below) means the registration statement on Form S-3 (No. 333- 136173 ).

 



 

Underwriter

 

Number of Shares
Of Initial
Underwritten Securities

 

 

 

 

 

Citigroup Global Markets Inc.

 

2,172,500

 

Morgan Stanley & Co. Incorporated

 

2,172,500

 

UBS Securities LLC

 

2,172,500

 

Wachovia Capital Markets, LLC

 

2,172,500

 

Deutsche Bank Securities Inc.

 

330,000

 

J.P. Morgan Securities Inc.

 

330,000

 

Morgan Keegan & Company, Inc.

 

330,000

 

Greenwich Capital Markets, Inc.

 

330,000

 

Scotia Capital (USA) Inc.

 

330,000

 

Stifel, Nicolaus & Company, Incorporated

 

330,000

 

Wells Fargo Securities, LLC

 

330,000

 

 

 

 

 

Total:

 

11,000,000

 

 

The Underwritten Securities shall have the following terms:

 

Title of securities :

 

Depositary Shares each representing 1/10th of a 8.375% Series O Cumulative Redeemable Preferred Share (Par Value $0.01 Per Share) (Liquidation Preference Equivalent to $25.00 Per Depositary Share).

 

 

 

Number of shares :

 

11,000,000 Depositary Shares

 

 

 

Public offering price per share :

 

$25.00, plus accumulated dividends, if any, from the date of original issue.

 

 

 

Purchase price per share :

 

$24.2125

 

 

 

Number of Option Securities, if any, that may be purchased by the Underwriters :

 

1,650,000 Depositary Shares

 

 

 

Dividend rate :

 

Cumulative dividends in the amount of 8.375% of the liquidation preference per annum (equivalent to $2.09375 per annum per Depositary Share); payable quarterly on or about March 31, June 30, September 30 and December 31 of each year, beginning March 31, 2008.

 

 

 

Voting and other rights :

 

If distributions on the Series O Preferred Shares are in arrears for six or more quarterly periods, whether or not consecutive, holders of the Underwritten Securities (voting separately as a class with all other series of preferred shares upon which like voting rights have been conferred and are exercisable) will be entitled to vote for the election of two additional Directors to serve on the Board of Directors of the

 

2



 

 

 

Company until all distribution arrearages are paid.

 

 

 

Joint Book-Runners :

 

Citigroup Global Markets Inc., Morgan Stanley & Co. Incorporated, UBS Securities LLC and Wachovia Capital Markets, LLC

 

 

 

Liquidation preference :

 

$25.00 per Depositary Share.

 

 

 

Ranking :

 

The Underwritten Securities will rank pari passu with any other outstanding preferred shares (except the Series C Junior Preferred Stock to which the Underwritten Securities rank senior) and will rank senior to the Common Stock of the Company and any other shares of the Company ranking junior to the Series O Preferred Shares.

 

 

 

Conversion provision :

 

The Series O Preferred Shares are not convertible or exchangeable for any other property or securities of the Company.

 

 

 

Redemption provisions :

 

The Depositary Shares may be redeemed, in whole or in part at the option of the Company, as of February 22, 2013, at a redemption price of $25.00 per Depositary Share, plus accrued and unpaid distributions thereon to the date fixed for redemption, without interest.

 

 

 

Sinking fund provisions :

 

None.

 

 

 

Closing time, date and location :

 

February 22, 2008, 10:00 a.m., New York City Time, Clifford Chance US LLP, 31 West 52 nd  Street, New York, New York 10019.

 

 

 

Other Terms :

 

Section 3(o) of the Underwriting Agreement is inapplicable to this transaction.

 

Underwriting Agreement :

 

Except as expressly provided herein, all the provisions contained in the document attached as Annex A hereto entitled “Duke Realty Corporation and Duke Realty Limited Partnership — Common Stock, Preferred Stock, Depositary Shares, Warrants, Stock Purchase Contracts, Duke Units and Debt Securities -  Underwriting Agreement”, dated August 17, 2006, are incorporated by reference in their entirety herein and shall be deemed to be a part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein.  Terms used but not defined shall have the meanings set forth in the Underwriting Agreement.  Notices to the Underwriters shall be directed to Wachovia Capital Markets, LLC, One Wachovia Center, 301 S. College Street, 6 th Floor, Charlotte, NC 28202, Attention: Transaction Management Group.

 

3



 

Please accept this offer no later than 10 o’clock P.M. (New York City time) on February 14, 2008 by signing a copy of this Terms Agreement in the space set forth below and returning the signed copy to us.

 

 

Very truly yours,

 

 

 

CITIGROUP GLOBAL MARKETS INC.

 

 

 

 

 

By:

 /s/ Scott Eisen

 

 

Name: Scott Eisen

 

 

Title: Managing Director

 

 

 

MORGAN STANLEY & CO. INCORPORATED

 

 

 

By:

 /s/ Yuri Slyt

 

 

Name: Yuri Slyt

 

 

Title:

 

 

 

 

 

UBS SECURITIES LLC

 

 

 

By:

 /s/ Jordan Matusow

 

 

Name: Jordan Matusow

 

 

Title: Director, UBS Investment Bank

 

 

 

 

 

By:

 /s/ Brendan Walker

 

 

Name: Brendan Walker

 

 

Title: Director, UBS Investment Bank

 

 

 

WACHOVIA CAPITAL MARKETS, LLC

 

 

 

 

 

By:

 /s/ Teresa Hee

 

 

Name: Teresa Hee

 

 

Title: Managing Director

 

 

 

For Themselves and as Representatives of the other named underwriters

 

 

 

 

Accepted:

 

 

 

DUKE REALTY CORPORATION

 

 

 

By:

 /s/ Howard L. Feinsand

 

 

Name: Howard L. Feinsand

 

 

Title: Executive Vice President, General

 

 

Counsel and Corporate Secretary

 

 

 

 



 

Annex A

 

DUKE REALTY CORPORATION

(an Indiana Corporation)

 

DUKE REALTY LIMITED PARTNERSHIP

(an Indiana limited partnership)

 

Common Stock, Preferred Stock, Depositary Shares, Warrants,

Stock Purchase Contracts, Duke Units and Debt Securities

 

UNDERWRITING AGREEMENT

 

August 17, 2006

 

The Representatives Named in the Terms Agreement

 

Ladies and Gentlemen:

 

Duke Realty Corporation (the “Company”) may from time to time offer in one or more series (i) shares of Common Stock, $.01 par value (the “Common Stock”), (ii) shares of preferred stock, $.01 par value (the “Preferred Stock”), (iii) shares of Preferred Stock represented by depositary shares (the “Depositary Shares”), (iv) warrants to purchase Common Stock, Preferred Stock and/or Depositary Shares (“Warrants”), (v) stock purchase contracts to purchase Common Stock, Preferred Stock and/or Depositary Shares (“Stock Purchase Contracts”), and (vi) units comprised of one or more of the Securities (as defined below) (“Duke Units”). Duke Realty Limited Partnership (the “Operating Partnership”) may from time to time offer in one or more series unsecured non-convertible investment grade debt securities (the “Debt Securities”).  The Common Stock, Preferred Stock, Depositary Shares, Warrants, Stock Purchase Contracts, Duke Units and Debt Securities (collectively, the “Securities”) may be offered, separately or together, in separate series, in amounts, at prices and on terms to be set forth in one or more Prospectus Supplements as hereinafter defined.  The Debt Securities will be issued under one or more indentures, as amended or supplemented (each, an “Indenture”), between the Operating Partnership and a trustee (a “Trustee”).  Each series of Debt Securities may vary, as applicable, as to aggregate principal amount, maturity date, interest rate or formula and timing of payments thereof, redemption or repayment provisions, and any other variable terms which the Indenture contemplates may be set forth in the Debt Securities as issued from time to time.  As used herein, “the Representatives,” unless the context otherwise requires, shall mean the parties, identified in the applicable Terms Agreement (as hereinafter defined) as the Representatives with respect to Underwritten Securities (as hereinafter defined) purchased pursuant thereto.

 

Whenever the Company or the Operating Partnership determines to make an offering of Securities through the Representatives or through an underwriting syndicate managed by the Representatives, the Company or the Operating Partnership, as the case may be, will enter into an agreement (the “Terms Agreement”) providing for the sale of such Securities (the “Underwritten Securities”) to, and the purchase and offering thereof by, the Representatives and such other underwriters, if any, selected by the Representatives as have authorized the Representatives to enter into such Terms Agreement on their behalf (the “Underwriters,” which term shall include the Representatives whether acting alone in the sale of the Underwritten Securities or as a member of an underwriting syndicate and any Underwriter

 



 

substituted pursuant to Section 10 hereof).  In addition to specifying the names of the Representatives, the Terms Agreement relating to the offering of Underwritten Securities shall specify the amount of Underwritten Securities to be initially issued (the “Initial Securities”), the names of the Underwriters participating in such offering (subject to substitution as provided in Section 10 hereof), the amount of Initial Securities which each such Underwriter severally agrees to purchase, the price at which the Initial Securities are to be purchased by the Underwriters from the Company or the Operating Partnership, as the case may be, the initial public offering price, if any, of the Initial Securities, the form, time, date and place of delivery and payment, any delayed delivery arrangements and any other variable terms of the Initial Securities (including, but not limited to, current ratings, designations, liquidation preferences, voting and other rights, denominations, interest rates or formulas, interest payment dates, maturity dates and redemption or repayment provisions applicable to the Initial Securities).  In addition, each Terms Agreement shall specify whether the Underwriters will be granted an option to purchase additional Underwritten Securities to cover over-allotments, if any, and the aggregate amount of Underwritten Securities subject to such option (the “Option Securities”).  As used herein, the term “Underwritten Securities” shall include the Initial Securities and all or any portion of the Option Securities agreed to be purchased by the Underwriters as provided herein, if any.  The Terms Agreement, which shall be substantially in the form of Exhibit A hereto, may take the form of an exchange of any standard form of written telecommunication between the Representatives and the Company or the Operating Partnership, as the case may be.  Each offering of Underwritten Securities through the Representatives or through an underwriting syndicate managed by the Representatives will be governed by this Agreement, as supplemented by the applicable Terms Agreement.

 

The Company and the Operating Partnership have filed with the Securities and Exchange Commission (the “Commission”) an automatic shelf registration statement on Form S-3 (No. 333-136173) for the registration of the Securities under the Securities Act of 1933, as amended (the “1933 Act”), and the offering thereof from time to time in accordance with Rule 430A or Rule 415 of the rules and regulations of the Commission under the 1933 Act (the “1933 Act Regulations”), and the Company and the Operating Partnership have filed such amendments thereto as may have been required prior to the execution of the applicable Terms Agreement.  Such registration statement (as amended, if applicable), pursuant to the 1933 Act and the 1933 Act Regulations, automatically became effective upon the filing thereof with the Commission, and the Indenture included in such registration statement has been qualified under the Trust Indenture Act of 1939, as amended (the “1939 Act”).  Such registration statement, as amended to the date of the applicable Terms Agreement, including the information, if any, deemed to be part thereof pursuant to Rule 430A or Rule 430(B) of the 1933 Act Regulations, and the prospectus constituting a part thereof in the form first used to confirm sales of the Underwritten Securities (or in the form first made available to the Representatives to meet requests of purchasers pursuant to Rule 173 under the 1933 Act) (the “Basic Prospectus”), together with each prospectus supplement specifically relating to the offering of Underwritten Securities in the form first used to confirm sales of the Underwritten Securities (or in the form first made available to the Representatives to meet requests of purchasers pursuant to Rule 173 under the 1933 Act) pursuant to Rule 415 of the 1933 Act Regulations (each, a “Prospectus Supplement”), including all documents incorporated therein by reference, as from time to time amended or supplemented pursuant to the 1933 Act, the Securities Exchange Act of 1934, as amended (the “1934 Act”) or otherwise, are collectively referred to herein as the “Registration Statement” and the “Prospectus,” respectively; and the term “preliminary prospectus” means the Basic Prospectus together with any preliminary form of the Prospectus Supplement.  For purposes of this Agreement, “free writing prospectus” has the meaning set forth in Rule 405 under the 1933 Act and “Time of Sale Prospectus” means the Basic Prospectus and, if any preliminary prospectus is used, the preliminary prospectus together with the free writing prospectuses, if any, each identified in Schedule I to the applicable Terms Agreement.  Any registration statement (including any supplement thereto or information which is deemed part thereof) filed by the Company or the Operating Partnership under Rule 462(b) of the 1933 Act Regulations (a “Rule 462(b) Registration Statement”) shall be deemed to be part

 

A-1



 

of the Registration Statement.  Any prospectus (including any amendment or supplement thereto or information which is deemed part thereof) included in the Rule 462(b) Registration Statement shall be deemed to be part of the Prospectus.  The term “Time of Sale Prospectus” shall also include the documents, if any, incorporated by reference therein.  All references in this Agreement to financial statements and schedules and other information which is “contained,” “included” or “stated” in the Registration Statement, the Time of Sale Prospectus, the Prospectus, or the free writing prospectuses (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Time of Sale Prospectus, the Prospectus, or the free writing prospectuses, as the case may be; and all references in this Agreement to amendments or supplements to the Registration Statement, the Time of Sale Prospectus, the Prospectus, or the free writing prospectuses shall be deemed to mean and include the filing of any document under the 1934 Act which is or is deemed to be incorporated by reference in the Registration Statement, the Time of Sale Prospectus, the Prospectus, or the free writing prospectuses, as the case may be.

 

The term “subsidiary” means a corporation or a partnership a majority of the outstanding voting stock or partnership interests, as the case may be, of which is owned or controlled, directly or indirectly, by the Company or the Operating Partnership, as the case may be, or by one or more other subsidiaries of the Company or the Operating Partnership.

 

SECTION 1.           Representations and Warranties of the Company and the Operating Partnership .

 

(b)   The Company and the Operating Partnership represent and warrant, jointly and severally, to the Representatives, as of the date hereof, and to the Representatives and each other Underwriter named in the applicable Terms Agreement, as of the date thereof, as of the Closing Time (as defined below) and, if applicable, as of each Date of Delivery (as defined below) (in each case, a “Representation Date”), as follows:

 

(i)            Pursuant to the 1933 Act and the 1933 Act Regulations, the Registration Statement automatically became effective upon the filing thereof with the Commission; no stop order suspending the effectiveness of the Registration Statement has been received by the Company, and, to the Company’s knowledge, no proceedings for such purpose are pending before or threatened by the Commission or by the state securities authority of any jurisdiction, and any request on the part of the Commission for additional information has been complied with.  The Registration Statement is an “automatic effective registration statement” as defined under Rule 405 of the 1933 Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the 1933 Act has been received by the Company or the Operating Partnership.  No stop order preventing or suspending the use of the Time of Sale Prospectus or the Prospectus has been received by the Company, and, to the Company’s knowledge, no proceedings for such purpose are pending before or threatened by the Commission or by the state securities authority of any jurisdiction.  If the Registration Statement is an automatic shelf registration statement as defined in Rule 405 under the 1933 Act, the Company or the Operating Partnership, as applicable, is a well-known seasoned issuer (as defined in Rule 405 under the 1933 Act) eligible to use the Registration Statement as an automatic shelf registration statement and the Company or the Operating Partnership, as applicable has not received notice that the Commission objects to the use of the Registration Statement as an automatic shelf registration statement.

 

A-2



 

(ii)           The Registration Statement at the time the Registration Statement became effective, complied, and as of each Representation Date will comply, in all material respects with the requirements of the 1933 Act, the 1933 Act Regulations and the 1939 Act and the rules and regulations thereunder (the “1939 Act Regulations”).  The Registration Statement, at the time the Registration Statement became effective, did not, and as of each Representation Date, will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.  The Time of Sale Prospectus, at the time of each sale of the applicable Underwritten Securities (the “Applicable Time”), the Closing Time and the Date of Delivery, if any, as then amended or supplemented by the Company, if applicable, will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.  The Prospectus, as of its date and as of the Closing Time and Date of Delivery, if any, will not, include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.  Notwithstanding the foregoing, however, the representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement, the Time of Sale Prospectus or the Prospectus made in reliance upon and in conformity with information furnished to the Company or the Operating Partnership in writing by any Underwriter through the Representatives expressly for use in the Registration Statement, the Time of Sale Prospectus or the Prospectus or to that part of the Registration Statement which shall constitute the Statement of Eligibility on Form T-1 under the 1939 Act (the “Statement of Eligibility”) of a Trustee under an Indenture.  If a Rule 462(b) Registration Statement is required in connection with the offering and sale of the Securities, the Company and the Operating Partnership have complied or will comply with the requirements of Rule 111 under the 1933 Act Regulations relating to the payment of filing fees therefor.

 

(iii)          Each preliminary prospectus, the Time of Sale Prospectus, the Prospectus, and any Prospectus Supplement filed as part of the Registration Statement as originally filed or as part of any amendment thereto, or filed pursuant to Rule 424 or Rule 433 (to the extent prepared by the Company) under the 1933 Act, complied or will comply when so filed in all material respects with the 1933 Act and the 1933 Act Regulations thereunder.

 

(iv)          The documents incorporated or deemed to be incorporated by reference in the Registration Statement, the Time of Sale Prospectus and the Prospectus pursuant to Item 12 of Form S-3 under the 1933 Act, at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with the requirements of the 1934 Act and the rules and regulations of the Commission under the 1934 Act (the “1934 Act Regulations”), and, when read together with the other information in the Prospectus, at the time the Registration Statement became effective and as of the applicable Representation Date or during the period specified in Section 3(f), did not and will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

(v)           Each of the Company and the Operating Partnership is not an “ineligible issuer” in connection with the offering of the applicable Underwritten Securities pursuant to Rules 164, 405 and 433 under the 1933 Act.  Any free writing prospectus that the Company or the Operating Partnership is required to file pursuant to Rule 433(d) under the 1933 Act has been, or will be, filed with the Commission in accordance with the requirements of the 1933 Act and the applicable rules and regulations of the Commission thereunder.  Each free writing prospectus that the Company and the Operating Partnership has filed, or is required to file, pursuant to

 

A-3



 

Rule 433(d) under the 1933 Act or that was prepared by or on behalf of or used or referred to by the Company and the Operating Partnership complies or will comply in all material respects with the requirements of the 1933 Act and the applicable rules and regulations of the Commission thereunder.  Except for the free writing prospectuses, if any, identified in Schedule I to the applicable Terms Agreement, and electronic road shows each furnished to you before first use, if any, the Company has not prepared, used or referred to, and will not, without your prior consent, prepare, use or refer to, any free writing prospectus.

 

(vi)          KPMG LLP, the accounting firm that audited the financial statements and supporting schedules included in, or incorporated by reference into, the Registration Statement, Time of Sale Prospectus and the Prospectus, are independent public accountants as required by the 1933 Act and the 1933 Act Regulations.

 

(vii)         The financial statements included in, or incorporated by reference into, the Registration Statement, Time of Sale Prospectus and the Prospectus, together with the related schedules and notes, present fairly the financial position of the respective entity or entities presented therein at the respective dates indicated and the results of their operations for the respective periods specified.  Except as otherwise stated in the Registration Statement, Time of Sale Prospectus and the Prospectus, said financial statements have been prepared in conformity with generally accepted accounting principles